Business Description
Corvus Pharmaceuticals is a US-based clinical-stage company focused on developing treatments that work by targeting key proteins involved in immune system function. Its pipeline includes three main drug candidates currently in clinical trials for conditions ranging from certain cancers to inflammatory and autoimmune diseases. The company supports its research through licensing partnerships with several academic and commercial organizations. Founded in 2014 and headquartered in South San Francisco, California, Corvus is working to bring forward a new generation of immune-based therapies.
